Ocrelizumab in Primary Progressive and Relapsing Multiple Sclerosis

被引：55
|
作者：
Mildiner, Sorcha [1 ]
Malnick, Stephen [1 ]
机构：
[1] Kaplan Med Ctr, Rehovot, Israel
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2017年 / 376卷 / 17期
关键词：
D O I：
10.1056/NEJMc1702076
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1692 / 1693
页数：2
相关论文
共 50 条
  • [1] Ocrelizumab in Primary Progressive and Relapsing Multiple Sclerosis REPLY
    Hauser, Stephen L.
    Belachew, Shibeshih
    Kappos, Ludwig
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (17): : 1694 - 1694
  • [2] Safety of Ocrelizumab in Patients With Relapsing and Primary Progressive Multiple Sclerosis
    Hauser, Stephen L.
    Kappos, Ludwig
    Montalban, Xavier
    Craveiro, Licinio
    Chognot, Cathy
    Hughes, Richard
    Koendgen, Harold
    Pasquarelli, Noemi
    Pradhan, Ashish
    Prajapati, Kalpesh
    Wolinsky, Jerry S.
    NEUROLOGY, 2021, 97 (16) : E1546 - E1559
  • [3] Infections and serious infections with ocrelizumab in relapsing multiple sclerosis and primary progressive multiple sclerosis
    Hartung, H. -P.
    Arnold, D. L.
    Bar-Or, A.
    Comi, G.
    de Seze, J.
    Giovannoni, G.
    Hauser, S. L.
    Hemmer, B.
    Kappos, L.
    Lublin, F.
    Montalban, X.
    Rammohan, K. W.
    Selmaj, K.
    Traboulsee, A.
    Chin, P.
    Li, C.
    Mairon, N.
    Napieralski, J.
    Wolinsky, J.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 658 - 659
  • [4] Infections and serious infections with ocrelizumab in relapsing multiple sclerosis and primary progressive multiple sclerosis
    Rammohan, Kottil W.
    Hartung, Hans-Peter
    Arnold, Douglas L.
    Bar-Or, Amit
    Comi, Giancarlo
    de Seze, Jerome
    Giovannoni, Gavin
    Hauser, Stephen L.
    Hemmer, Bernhard
    Kappos, Ludwig
    Lublin, Fred
    Montalban, Xavier
    Selmaj, Krzysztof
    Traboulsee, Anthony
    Chin, Peter
    Li, Carrie
    Mairon, Nicole
    Napieralski, Julie
    Wolinsky, Jerry
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (01) : 31 - 32
  • [5] Safety of ocrelizumab in multiple sclerosis: updated analysis in patients with relapsing and primary progressive multiple sclerosis
    Hauser, S. L.
    Kappos, L.
    Montalban, X.
    Craveiro, L.
    Hughes, R.
    McNamara, J.
    Pradhan, A.
    Wormser, D.
    Koendgen, H.
    Wolinsky, J. S.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 317 - 318
  • [6] Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients With Relapsing and Primary Progressive Multiple Sclerosis
    Hauser, Stephen L.
    Kappos, Ludwig
    Montalban, Xavier
    Craveiro, Licinio
    Hughes, Richard
    Prajapati, Kalpesh
    Koendgen, Harold
    Pradhan, Ashish
    Wolinsky, Jerry S.
    NEUROLOGY, 2020, 94 (15)
  • [7] Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients With Relapsing and Primary Progressive Multiple Sclerosis
    Hauser, S. L.
    Kappos, L.
    Montalban, X.
    Craveiro, L.
    Hughes, R.
    Prajapati, K.
    Koendgen, H.
    Pradhan, A.
    Wolinsky, J. S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 331 - 331
  • [8] Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients With Relapsing and Primary Progressive Multiple Sclerosis
    Hauser, Stephen L.
    Kappos, Ludwig
    Montalban, Xavier
    Chognot, Cathy
    Jessop, Nikki
    Pradhan, Ashish
    Prajapati, Kalpesh
    Wolinsky, Jerry S.
    NEUROLOGY, 2021, 96 (15)
  • [9] Safety of ocrelizumab in multiple sclerosis: updated analysis in patients with relapsing and primary progressive multiple sclerosis
    Hauser, S. L.
    Kappos, L.
    Montalban, X.
    Guittari, C. J.
    Koendgen, H.
    Li, C.
    Marcillat, C.
    Wormser, D.
    Wolinsky, J. S.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 324 - 325
  • [10] Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients With Relapsing and Primary Progressive Multiple Sclerosis
    Hauser, Stephen
    Kappos, Ludwig
    Montalban, Xavier
    Koendgen, Harold
    Li, Carrie
    Marcillat, Carole
    Pradhan, Ashish
    Wormser, David
    Wolinsky, Jerry
    NEUROLOGY, 2018, 90
12345